AI Biomed PredictionsCVKD – Phase 3 clarity could revive battered microcap HIT story ScanScor Admin / April 17, 2026
AI Biomed PredictionsKROS – Keros faces make-or-break DMD launch window in Q2 ScanScor Admin / April 16, 2026
AI Biomed PredictionsMBRX – Mid-2026 AML unblinding could redefine tiny-cap MBRX valuation ScanScor Admin / April 16, 2026
AI Biomed PredictionsKRRO – Korro’s next AATD nomination may reignite platform-belief rally ScanScor Admin / April 15, 2026
AI Biomed PredictionsNRXP – Summer FDA Ketamine Decision Could Reawaken NRXP Speculation ScanScor Admin / April 13, 2026
AI Biomed PredictionsBIVI – BioVie’s next real test is the mid-2026 Parkinson’s readout ScanScor Admin / April 12, 2026
AI Biomed PredictionsCNTB – Midyear Seabreeze data could decide CNTB’s next breakout ScanScor Admin / April 12, 2026
AI Biomed PredictionsVRCA – VP-315 conference data could ignite VRCA’s next squeeze rally ScanScor Admin / April 12, 2026
AI Biomed PredictionsSPRO – Spero Therapeutics Nears Potential Breakout with FDA Decision ScanScor Admin / April 11, 2026
AI Biomed PredictionsENTX – Entera Bio Nears Major Catalyst with EB613, Eyeing Breakout ScanScor Admin / April 3, 2026
